These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis. Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479 [TBL] [Abstract][Full Text] [Related]
10. A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement. Bunaux K; Sevestre H; Emile JF; Capel C; Chenin L; Peltier J Neurochirurgie; 2018 Dec; 64(6):439-441. PubMed ID: 30274919 [TBL] [Abstract][Full Text] [Related]
13. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Haroche J; Abla O Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774 [TBL] [Abstract][Full Text] [Related]
14. Advances in Understanding and Management of Erdheim-Chester Disease. Kulkarni AM; Gayam PKR; Aranjani JM Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283 [TBL] [Abstract][Full Text] [Related]
15. Erdheim-Chester Disease: a comprehensive review of the literature. Mazor RD; Manevich-Mazor M; Shoenfeld Y Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030 [TBL] [Abstract][Full Text] [Related]
16. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028 [TBL] [Abstract][Full Text] [Related]
19. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033 [TBL] [Abstract][Full Text] [Related]
20. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y J Neurosurg Pediatr; 2019 Jan; 23(1):48-53. PubMed ID: 30265230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]